{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:59:12Z","timestamp":1789693152394,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360519"],"award-info":[{"award-number":["82360519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cell division cycle associated 7 (CDCA7) plays a role in various malignancies, especially pancreatic cancer (PC). However, its expression pattern and functional significance in PC require further research. Therefore, this study aimed to investigate CDCA7 expression levels and biological functions in PC using in vitro and in vivo experiments. Western blotting, immunohistochemistry, and real-time polymerase chain reaction were performed to detect CDCA7 expression in PC cells and tissues. Additionally, the biological functions of CDCA7 were assessed using cell proliferation, wound healing, and Transwell assays. CDCA7 overexpression promoted PC cell proliferation, migration, and invasion, and increased resistance to the chemotherapy drug gemcitabine, possibly through enhanced aerobic glycolysis. Additionally, immunoprecipitation assay showed that CDCA7 interacted with STAT3 protein and affected the transcriptional regulation of hexokinase 2. Conclusively, targeting CDCA7 might be a promising therapeutic strategy to increase gemcitabine sensitivity by inhibiting glycolysis in PC cells.<\/jats:p>","DOI":"10.1038\/s41419-025-07399-1","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T19:52:21Z","timestamp":1738698741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["CDCA7 enhances STAT3 transcriptional activity to regulate aerobic glycolysis and promote pancreatic cancer progression and gemcitabine resistance"],"prefix":"10.1038","volume":"16","author":[{"given":"Dijie","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9244-9416","authenticated-orcid":false,"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"7399_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin."},{"key":"7399_CR2","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/jama.2019.14699","volume":"322","author":"A Moore","year":"2019","unstructured":"Moore A, Donahue T. Pancreatic Cancer. JAMA 2019;322:1426.","journal-title":"JAMA"},{"key":"7399_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u20132921.","journal-title":"Cancer Res"},{"key":"7399_CR4","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","volume":"34","author":"T Conroy","year":"2023","unstructured":"Conroy T, Pfeiffer P, Vilgrain V, Lamarca A, Seufferlein T, O\u2019Reilly EM, et al. Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:987\u20131002.","journal-title":"Ann Oncol."},{"key":"7399_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101234","volume":"4","author":"R Tang","year":"2023","unstructured":"Tang R, Xu J, Wang W, Meng Q, Shao C, Zhang Y, et al. Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response. Cell Rep Med. 2023;4:101234.","journal-title":"Cell Rep Med."},{"key":"7399_CR6","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1158\/0008-5472.CAN-05-0536","volume":"65","author":"RC Osthus","year":"2005","unstructured":"Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt M, Huso DL, et al. The Myc target gene JPO1\/CDCA7 is frequently overexpressed in human tumors and has limited transforming activity in vivo. Cancer Res 2005;65:5620\u20137.","journal-title":"Cancer Res"},{"key":"7399_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1128\/MCB.00276-12","volume":"33","author":"RM Gill","year":"2013","unstructured":"Gill RM, Gabor TV, Couzens AL, Scheid MP. The MYC-associated protein CDCA7 is phosphorylated by AKT to regulate MYC-dependent apoptosis and transformation. Mol Cell Biol. 2013;33:498\u2013513.","journal-title":"Mol Cell Biol."},{"key":"7399_CR8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/genes14071406","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhao Y, Zhang Z, Zhang J, Xu Q, Zhou X, et al. High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity. Genes (Basel). 2023;14:1406.","journal-title":"Genes (Basel)"},{"key":"7399_CR9","first-page":"57","volume":"22","author":"S Li","year":"2020","unstructured":"Li S, Huang J, Qin M, Zhang J, Liao C. High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer. Mol Med Rep. 2020;22:57\u201366.","journal-title":"Mol Med Rep."},{"key":"7399_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/cas.15560","volume":"114","author":"H Li","year":"2023","unstructured":"Li H, Wang S, Li X, Weng Y, Guo D, Kong P, et al. CDCA7 promotes TGF-beta-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4\/Smad7 in ESCC. Cancer Sci. 2023;114:91\u2013104.","journal-title":"Cancer Sci."},{"key":"7399_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/biof.1773","volume":"47","author":"Y Guo","year":"2021","unstructured":"Guo Y, Zhou K, Zhuang X, Li J, Shen X. CDCA7-regulated inflammatory mechanism through TLR4\/NF-kappaB signaling pathway in stomach adenocarcinoma. Biofactors 2021;47:865\u201378.","journal-title":"Biofactors"},{"key":"7399_CR12","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1080\/21655979.2021.1965441","volume":"12","author":"C Cai","year":"2021","unstructured":"Cai C, Peng X, Zhang Y. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression. Bioengineered. 2021;12:7007\u201319.","journal-title":"Bioengineered."},{"key":"7399_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2174\/1568009013334241","volume":"1","author":"MG Walker","year":"2001","unstructured":"Walker MG. Drug target discovery by gene expression analysis: cell cycle genes. Curr Cancer Drug Targets 2001;1:73\u201383.","journal-title":"Curr Cancer Drug Targets"},{"key":"7399_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/JTO.0b013e3182352a45","volume":"7","author":"J Hou","year":"2012","unstructured":"Hou J, Lambers M, den Hamer B, den Bakker MA, Hoogsteden HC, Grosveld F, et al. Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy. J Thorac Oncol. 2012;7:105\u201314.","journal-title":"J Thorac Oncol."},{"key":"7399_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01169-7","volume":"19","author":"C Qin","year":"2020","unstructured":"Qin C, Yang G, Yang J, Ren B, Wang H, Chen G, et al. Metabolism of pancreatic cancer: paving the way to better anticancer strategies. Mol Cancer 2020;19:50.","journal-title":"Mol Cancer"},{"key":"7399_CR16","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1136\/gutjnl-2015-309304","volume":"64","author":"A Neesse","year":"2015","unstructured":"Neesse A, Algul H, Tuveson DA, Gress TM. Stromal biology and therapy in pancreatic cancer: a changing paradigm. Gut 2015;64:1476\u201384.","journal-title":"Gut"},{"key":"7399_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2007.04.004","volume":"368","author":"H Jiang","year":"2008","unstructured":"Jiang H, Yu J, Guo H, Song H, Chen S. Upregulation of survivin by leptin\/STAT3 signaling in MCF-7 cells. Biochem Biophys Res Commun. 2008;368:1\u20135.","journal-title":"Biochem Biophys Res Commun."},{"key":"7399_CR18","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","volume":"45","author":"X Gao","year":"2012","unstructured":"Gao X, Wang H, Yang JJ, Liu X, Liu ZR. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 2012;45:598\u2013609.","journal-title":"Mol Cell"},{"key":"7399_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2012.09.013","volume":"48","author":"S Shen","year":"2012","unstructured":"Shen S, Niso-Santano M, Adjemian S, Takehara T, Malik SA, Minoux H, et al. Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell 2012;48:667\u201380.","journal-title":"Mol Cell"},{"key":"7399_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114168","volume":"158","author":"M Sadrkhanloo","year":"2023","unstructured":"Sadrkhanloo M, Paskeh MDA, Hashemi M, Raesi R, Motahhary M, Saghari S, et al. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions. Biomed Pharmacother. 2023;158:114168.","journal-title":"Biomed Pharmacother."},{"key":"7399_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.116458","volume":"233","author":"M Hashemi","year":"2023","unstructured":"Hashemi M, Abbaszadeh S, Rashidi M, Amini N, Talebi Anaraki K, Motahhary M, et al. STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological\/nanoplatform strategies. Environ Res. 2023;233:116458.","journal-title":"Environ Res."},{"key":"7399_CR22","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1038\/s41388-021-01957-5","volume":"40","author":"H Li","year":"2021","unstructured":"Li H, Qi Z, Niu Y, Yang Y, Li M, Pang Y, et al. FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC\/STAT3 signaling axis in ovarian cancer. Oncogene 2021;40:5938\u201349.","journal-title":"Oncogene"},{"key":"7399_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11010-021-04284-1","volume":"477","author":"W Zhu","year":"2022","unstructured":"Zhu W, Sheng D, Shao Y, Zhang Q, Peng Y. STAT3-regulated LncRNA LINC00160 mediates cell proliferation and cell metabolism of prostate cancer cells by repressing RCAN1 expression. Mol Cell Biochem. 2022;477:865\u201375.","journal-title":"Mol Cell Biochem."},{"key":"7399_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04081-0","volume":"12","author":"N Huo","year":"2021","unstructured":"Huo N, Cong R, Sun ZJ, Li WC, Zhu X, Xue CY, et al. STAT3\/LINC00671 axis regulates papillary thyroid tumor growth and metastasis via LDHA-mediated glycolysis. Cell Death Dis. 2021;12:799.","journal-title":"Cell Death Dis."},{"key":"7399_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41556-019-0299-0","volume":"21","author":"F Chen","year":"2019","unstructured":"Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y, et al. Extracellular vesicle-packaged HIF-1alpha-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21:498\u2013510.","journal-title":"Nat Cell Biol."},{"key":"7399_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2014.12.020","volume":"81","author":"V Bosello-Travain","year":"2015","unstructured":"Bosello-Travain V, Forman HJ, Roveri A, Toppo S, Ursini F, Venerando R, et al. Glutathione peroxidase 8 is transcriptionally regulated by HIFalpha and modulates growth factor signaling in HeLa cells. Free Radic Biol Med. 2015;81:58\u201368.","journal-title":"Free Radic Biol Med."},{"key":"7399_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/MPA.0000000000001124","volume":"47","author":"SE Henderson","year":"2018","unstructured":"Henderson SE, Makhijani N, Mace TA. Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models. Pancreas 2018;47:937\u201345.","journal-title":"Pancreas"},{"key":"7399_CR28","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/jcmm.13126","volume":"21","author":"H Zhao","year":"2017","unstructured":"Zhao H, Duan Q, Zhang Z, Li H, Wu H, Shen Q, et al. Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells. J Cell Mol Med. 2017;21:2055\u201367.","journal-title":"J Cell Mol Med."},{"key":"7399_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, et al. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell 2017;32:71\u201387.e7.","journal-title":"Cancer Cell"},{"key":"7399_CR30","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1002\/1878-0261.13263","volume":"16","author":"Y Li","year":"2022","unstructured":"Li Y, Song Z, Han Q, Zhao H, Pan Z, Lei Z, et al. Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis. Mol Oncol. 2022;16:2861\u201380.","journal-title":"Mol Oncol."},{"key":"7399_CR31","doi-asserted-by":"publisher","first-page":"24777","DOI":"10.18632\/oncotarget.15801","volume":"8","author":"M Li","year":"2017","unstructured":"Li M, Jin R, Wang W, Zhang T, Sang J, Li N, et al. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells. Oncotarget 2017;8:24777\u201384.","journal-title":"Oncotarget"},{"key":"7399_CR32","first-page":"1404","volume":"55","author":"H He","year":"2023","unstructured":"He H, Guo J, Hu Y, Zhang H, Li X, Zhang J, et al. Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2\/glycolysis signaling. Acta Biochim Biophys Sin. (Shanghai) 2023;55:1404\u201314.","journal-title":"Acta Biochim Biophys Sin. (Shanghai)"},{"key":"7399_CR33","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1096\/fj.201901237R","volume":"34","author":"SH Jiang","year":"2020","unstructured":"Jiang SH, Dong FY, Da LT, Yang XM, Wang XX, Weng JY, et al. Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2. FASEB J. 2020;34:3943\u201355.","journal-title":"FASEB J."},{"key":"7399_CR34","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1002\/cam4.2463","volume":"8","author":"K Fan","year":"2019","unstructured":"Fan K, Fan Z, Cheng H, Huang Q, Yang C, Jin K, et al. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer. Cancer Med. 2019;8:5903\u201315.","journal-title":"Cancer Med."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07399-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07399-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07399-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T19:52:23Z","timestamp":1738698743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07399-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7399"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07399-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"15 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures followed were in accordance with the ethical standards of the Ethical Committee of the Affiliated Hospital of Guizhou Medical University. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"68"}}